Literature DB >> 26746864

Neuronal HIF-1α and HIF-2α deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke.

Philipp Barteczek1, Lexiao Li1, Anne-Sophie Ernst1, Laura-Inés Böhler1, Hugo H Marti1, Reiner Kunze2.   

Abstract

Hypoxia-inducible factors mediate adaptive responses to ischemia, among others, by induction of anti- and pro-survival genes. Thus, the impact of HIF on neuronal survival upon stroke is controversial. Therefore, neuron-specific knockout mice deficient for Hif1a and Hif2a were exposed to inspiratory hypoxia or ischemia-reperfusion injury. Both Hif1a- and Hif2a-deficient mice showed no altered infarct and edema size, suggesting that both HIF-α subunits might compensate for each other. Accordingly, hypoxic HIF-target gene regulation was marginally affected with exception of anti-survival Bnip3 and pro-survival erythropoietin. In the early acute stage upon stroke, Hif1a/Hif2a double knockout mice exhibited significantly reduced expression of the anti-survival Bnip3, Bnip3L, and Pmaip1 Accordingly, global cell death and edema were significantly reduced upon 24 h but not 72 h reperfusion. Behavioral assessment indicated that Hif1a/Hif2a-deficient mice initially performed better, but became significantly more impaired after 72 h accompanied by increased apoptosis and reduced angiogenesis. Our findings suggest that in neurons HIF-1 and HIF-2 have redundant functions for cellular survival under ischemic conditions. By contrast, lack of anti-survival factors in Hif1a/Hif2a-deficient mice might protect from early acute neuronal cell death and neurological impairment, indicating a benefit of HIF-pathway inhibition in neurons in the very acute phase after ischemic stroke.
© The Author(s) 2016.

Entities:  

Keywords:  Erythropoietin; hypoxia-inducible factor; ischemia; stroke; vascular endothelial growth factor

Mesh:

Substances:

Year:  2016        PMID: 26746864      PMCID: PMC5363746          DOI: 10.1177/0271678X15624933

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  58 in total

1.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

2.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

3.  Occlusion of the MCA by an intraluminal filament may cause disturbances in the hippocampal blood flow due to anomalies of circle of Willis and filament thickness.

Authors:  Y G Ozdemir; H Bolay; E Erdem; T Dalkara
Journal:  Brain Res       Date:  1999-03-20       Impact factor: 3.252

4.  Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.

Authors:  Reiner Kunze; Wei Zhou; Roland Veltkamp; Ben Wielockx; Georg Breier; Hugo H Marti
Journal:  Stroke       Date:  2012-08-28       Impact factor: 7.914

5.  Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage.

Authors:  Rob Helton; Jiankun Cui; John R Scheel; Julie A Ellison; Chris Ames; Claire Gibson; Barbara Blouw; Ling Ouyang; Ioannis Dragatsis; Scott Zeitlin; Randall S Johnson; Stuart A Lipton; Carrolee Barlow
Journal:  J Neurosci       Date:  2005-04-20       Impact factor: 6.167

6.  Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.

Authors:  Ambreena Siddiq; Issam A Ayoub; Juan C Chavez; Leila Aminova; Sapan Shah; Joseph C LaManna; Stephanie M Patton; James R Connor; Robert A Cherny; Irene Volitakis; Ashley I Bush; Ingrid Langsetmo; Todd Seeley; Volkmar Gunzler; Rajiv R Ratan
Journal:  J Biol Chem       Date:  2005-10-13       Impact factor: 5.157

7.  Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.

Authors:  Heidi Menrad; Christian Werno; Tobias Schmid; Ekaterini Copanaki; Thomas Deller; Nathalie Dehne; Bernhard Brüne
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

8.  Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain.

Authors:  Heike J Schoch; Silvia Fischer; Hugo H Marti
Journal:  Brain       Date:  2002-11       Impact factor: 13.501

9.  Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke.

Authors:  Stefan Reischl; Lexiao Li; Gail Walkinshaw; Lee A Flippin; Hugo H Marti; Reiner Kunze
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

10.  BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha.

Authors:  Jee-Youn Kim; Hyun-Jong Ahn; Jong-Hoon Ryu; Kyoungho Suk; Jae-Hoon Park
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

View more
  36 in total

1.  The neuronal oxygen-sensing pathway controls postnatal vascularization of the murine brain.

Authors:  Emil Nasyrov; Karen A Nolan; Roland H Wenger; Hugo H Marti; Reiner Kunze
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.191

2.  Modulator of apoptosis-1 is a potential therapeutic target in acute ischemic injury.

Authors:  Su Jing Chan; Hui Zhao; Kazuhide Hayakawa; Chou Chai; Chong Teik Tan; Jiawen Huang; Ran Tao; Gen Hamanaka; Thiruma V Arumugam; Eng H Lo; Victor Chun Kong Yu; PeterTsun-Hon Wong
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-22       Impact factor: 6.200

3.  Caffeine inhibits hypoxia-induced nuclear accumulation in HIF-1α and promotes neonatal neuronal survival.

Authors:  Hsiu-Ling Li; Nahla Zaghloul; Ijaz Ahmed; Anton Omelchenko; Bonnie L Firestein; Hai Huang; Latoya Collins
Journal:  Exp Neurol       Date:  2019-02-26       Impact factor: 5.330

4.  Transient Focal Ischemia Significantly Alters the m6A Epitranscriptomic Tagging of RNAs in the Brain.

Authors:  Anil K Chokkalla; Suresh L Mehta; TaeHee Kim; Bharath Chelluboina; Jooyong Kim; Raghu Vemuganti
Journal:  Stroke       Date:  2019-08-22       Impact factor: 7.914

5.  Oxygen-Glucose Deprivation/Reoxygenation-Induced Barrier Disruption at the Human Blood-Brain Barrier is Partially Mediated Through the HIF-1 Pathway.

Authors:  Shyanne Page; Snehal Raut; Abraham Al-Ahmad
Journal:  Neuromolecular Med       Date:  2019-03-26       Impact factor: 3.843

6.  Neuronal deficiency of hypoxia-inducible factor 2α increases hypoxic-ischemic brain injury in neonatal mice.

Authors:  Dawei Sun; Fuxin Lu; Ann Sheldon; Xiangning Jiang; Donna M Ferriero
Journal:  J Neurosci Res       Date:  2021-09-06       Impact factor: 4.164

7.  Pharmacological HIF1 Inhibition Eliminates Downregulation of the Pentose Phosphate Pathway and Prevents Neuronal Apoptosis in Rat Hippocampus Caused by Severe Hypoxia.

Authors:  Oleg Vetrovoy; Kseniia Sarieva; Ekaterina Lomert; Peter Nimiritsky; Natalia Eschenko; Olga Galkina; Andrey Lyanguzov; Ekaterina Tyulkova; Elena Rybnikova
Journal:  J Mol Neurosci       Date:  2019-12-21       Impact factor: 3.444

8.  Sirt3 Protects Against Ischemic Stroke Injury by Regulating HIF-1α/VEGF Signaling and Blood-Brain Barrier Integrity.

Authors:  Xiao Yang; Yanshuang Zhang; Keyi Geng; Ke Yang; Jiaxiang Shao; Weiliang Xia
Journal:  Cell Mol Neurobiol       Date:  2020-06-04       Impact factor: 5.046

9.  Dexmedetomidine attenuates neuronal injury induced by cerebral ischemia‑reperfusion by regulating miR‑199a.

Authors:  Yulin Zhu; Huatang Zhao; Wenshan Zhang; Xingang Ma; Ye Liu
Journal:  Mol Med Rep       Date:  2021-06-10       Impact factor: 2.952

10.  MiR-206 Suppresses the Progression of Coronary Artery Disease by Modulating Vascular Endothelial Growth Factor (VEGF) Expression.

Authors:  Maojing Wang; Yang Ji; Shanglang Cai; Wei Ding
Journal:  Med Sci Monit       Date:  2016-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.